Furthermore, a lack of NELFB expression in breast carcinoma may serve as a useful indicator for poor prognosis (Aiyar et al. 2007; Sun et al. 2008), thus pointing at a beneficial role for NELFB. This evidence concerns the gene NELFB and breast carcinoma.